William Menzer is a medicinal chemist at Eisbach Bio GmbH, where they focus on the analysis and design of small molecule inhibitors and oversee CMC for select inhibitors in GLP toxicity studies and first-in-human clinical trials. They are also a Ph.D. candidate at the International Max Planck Research School for Molecular Life Sciences, working under Prof. Andreas Ladurner.
This person is not in any teams
This person is not in any offices